96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
α4β7 thioether peptide dimer antagonists
#902METHOD OF USING A TLR9 ANTAGONIST AS AN ANTI-INFLAMMATORY AND ANTI-FIBROTIC AGENT
#903Tertiary amino lipidated cationic peptides for nucleic acid delivery
#904Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
#905Personalized immunotherapy against several neuronal and brain tumors
#906Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#907LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
#908Therapeutic peptides
#909Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery
#910Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#911PROCESS FOR PREPARATION OF PURE PLECANATIDE
#912Artificial intelligence designed antimicrobial peptides
#913Vista antagonist and methods of use
#914MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#915Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereof
#916Immunogenic composition and use thereof
#917Peptides and combination of peptides for use in immunotherapy against various cancers
#918Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such
#919MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#920ANTIGENIC PEPTIDES AND USES THEREOF FOR DIAGNOSING AND TREATING AUTISM
#921METHODS OF PHYSICOCHEMICAL-GUIDED PEPTIDE DESIGN AND NOVEL PEPTIDES DERIVED THEREFROM
#922Immunotherapy against several tumors including neuronal and brain tumors
#923Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis
#924Peptides and combination of peptides for use in immunotherapy against various cancers
#925Rheumatoid arthritis auto-antibody-bound peptide and application thereof
#926NOVEL USE OF PEPTIDE FOR INHIBITING FUNCTIONS AND EXPRESSIONS OF MULTIPLE DISEASE BIOMARKERS
#927Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
#928Amyloid inhibitory peptides
#929Peptide fusion protein
#930Albumin binding peptide conjugates and methods thereof
#931USE OF A PDE11 OR PDE2 INHIBITOR FOR THE TREATMENT OF PARKINSON'S DISEASE
#932PEPTIDE COMPOSITIONS AND METHODS FOR INHIBITING NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY
#933Peptides for the treatment of covid-19
#934LIPID NANOPARTICLE FORMULATIONS COMPRISING LIPIDATED CATIONIC PEPTIDE COMPOUNDS FOR NUCLEIC ACID DELIVERY
#935ANTI HLA-G SPECIFIC ANTIBODIES
#936Methods for treatment and diagnosis of non-alcoholic steatohepatitis and/or hepatocellular carcinoma
#937COMPOSITIONS AND METHODS FOR TREATING CD40-MEDIATED DISEASES
#938THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS
#939Regulatory T cell epitopes
#940Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein
#941IL-17A binding peptides and medical uses thereof
#942Sterilization of self-assembling peptides by irradiation
#943Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof
#944CELL-PENETRATING PEPTIDES
#945Cell-penetrating peptides
#946Heterotandem bicyclic peptide complexes
#947Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
#948Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#949PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#950Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#951Peptides for use as cell-penetrating peptides
#952Peptides and combination of peptides for use in immunotherapy against various cancers
#953Peptides and combination of peptides for use in immunotherapy against various cancers
#954PEPTIDE MICROARRAYS AND NOVEL BIOMARKERS FOR CELIAC DISEASE
#955MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
#956Encryption device and operation method thereof
#957Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders
#958Peptides and combination of peptides for use in immunotherapy against various cancers
#959Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#960PLANT-DERIVED ELASTIN BINDING PROTEIN LIGANDS AND METHODS OF USING THE SAME
#961CYCLIC PEPTIDE AND A MEDICAMENT, EXTERNAL PREPARATION AND COSMETIC COMPRISING SAID CYCLIC PEPTIDE
#962Yeats inhibitors and methods of use thereof
#963PD-1 and CTLA-4 Dual Inhibitor Peptides
#964NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#965Peptide for regulating reactivity to serotonin reuptake inhibitor based antidepressant, and use thereof
#966BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4
#967SELF-ASSEMBLING PEPTIDE SCAFFOLD
#968Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers
#969Peptide ligands for binding to EphA2
#970Apelin polypeptides
#971SYNTHETIC PEPTIDE SP2 AND APPLICATION THEREOF
#972Compstatin analogs with increased solubility and improved pharmacokinetic properties
#973Immunotherapy against several tumors including neuronal and brain tumors
#974Dry powder formulation of caveolin-1 peptides and methods of use thereof
#975Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#976Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#977Methods for detection of botulinum neurotoxin
#978VISTA Antagonist and Methods of Use
#979EGFRvIII immunogen and methods for using same
#980Immunotherapy against several tumors including lung cancer
#981HETERODIMERIC PEPTIDE REAGENTS AND METHODS
#982Immunotherapy against several tumors including neuronal and brain tumors
#983Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics
#984Protein interfaces
#985Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#986Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#987NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#988Peptides for specific inhibition of Jag 1-Notch 1 pathway
#989Modulation of complement activity
#990MASP inhibitory compounds and uses thereof
#991Erythrocyte-binding therapeutics
#992MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#993OFF-THE-SHELF CANCER VACCINES
#994Elicitor peptides having disrupted hypersensitive response box and use thereof
#995Stapled H2 pyrin peptides
#996Immunotherapy against several tumors including neuronal and brain tumors
#997Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer
#998Peptide for treating cancer
#999Anticancer peptides
#1000Personalized immunotherapy against several neuronal and brain tumors
#1001Anti-inflammatory peptides and composition comprising the same
#1002APPLICATION OF PEDF-DERIVED SHORT PEPTIDES IN THE TREATMENT OF OSTEOARTHRITIS
#1003Peptide for treating rheumatoid arthritis and use thereof
#1004Targeted non-invasive imaging probes of EGFR expressing cells
#1005Peptide docking vehicle for targeted nucleic acid delivery
#1006Peptide, method and composition for melanin polymerization and hair darkening
#1007SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USE
#1008MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#1009Method for promoting nodulation in plants
#1010Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor
#1011Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
#1012PEPTIDIC LINKER WITH REDUCED POST-TRANSLATIONAL MODIFICATION
#1013CARDIAC-SPECIFIC TARGETING-PEPTIDE (CTP), COMPOSITIONS, AND USES THEREOF
#1014FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#1015ARRAY AND METHOD OF USE
#1016Peptidic TGF-beta antagonists
#1017Anti-Tumour Response to Modified Self-Epitopes
#1018EphA2 T-cell epitope agonists and uses therefore
#1019Peptides for targeting LRP6-overexpressed cells
#1020Cell-penetrating compstatin analogs and uses thereof
#1021Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
#1022PEPTIDES FOR USE IN PROMOTING TRANSPORT OF GLUCOSE
#1023Peptides and nanoparticle formulations thereof
#1024MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES
#1025Serpin peptides and methods of using the same
#1026Peptides and uses thereof for treating cancer
#1027COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS, AND METHODS OF USE THEREOF
#1028Synthetic peptide sp4 and use thereof
#1029Platform drug delivery system utilizing crystal engineering and theanine dissolution
#1030Self-assembling peptides comprising non-Ionic polar amino acids
#1031Modified antibody and radioactive metal-labelled antibody
#1032METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
#1033Peptide and use therefor
#1034Helper epitope peptide and application thereof
#1035Compounds for use as apelin receptor antagonists
#1036Methods of inhibiting integrin α9β1 activity
#1037Methods of diagnosis and treatment of tuberculosis and infection
#1038PEPTIDES DERIVED FROM PRORELAXIN H1 (RLN1)
#1039PEPTIDE LIGANDS FOR BINDING TO INTEGRIN
#1040Bicyclic peptide ligands and uses thereof
#1041Analogues of hepcidin mimetics with improved in vivo half lives
#1042PEPTIDE FOR INHIBITING BONE RESORPTION
#1043PEPTIDE-BASED INHIBITORS OF MARK FAMILY PROTEINS
#1044Inhibitors of blood coagulation factor XIII
#1045Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#1046PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS, PARTICULARLY HIV
#1047ANTISENSE COMPOSITION AND METHOD FOR TREATING MUSCLE ATROPHY
#1048PEPTIDES
#1049MULTIVALENT LIGAND-LIPID CONSTRUCTS
#1050Method of preparing stapled peptides
#1051CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES
#1052ELECTRODE FOR BIOELECTRONICS USING METAL-IMMOBILIZED PEPTIDE EXPRESSING ENZYME
#1053Hyperstable Constrained Peptides and Their Design
#1054Dual IL-2R and IL-7R binding compounds
#1055Synthetic peptides that modulate the NMDA receptor
#1056PEPTIDE, COMPOSITION, AND METHOD FOR TREATING, PREVENTING, OR AMELIORATING MOOD DISORDER
#1057Stapled peptides and uses thereof
#1058PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME
#1059Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules
#1060Hypersensitive response elicitor peptides and use thereof
#1061Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS
#1062Self-assembling peptide for activating human mast cells
#1063Modulation of structured polypeptide specificity
#1064PEPTIDE LIGANDS FOR BINDING TO IL-17
#1065PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF
#1066PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF
#1067CYCLIC PEPTIDE INHIBITORS OF HEDGEHOG PROTEINS
#1068Co-assembly peptides, nanostructures, and methods of making and using the same
#1069TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE
#1070NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS
#107114-3-3 targeting peptides for cancer treatment
#1072CD200 inhibitors and methods of use thereof
#1073NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#1074Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#1075Engineered cascade components and cascade complexes
#1076Modified antimicrobial peptide derived from an arginine-rich domain
#1077Bovine adrenal medulla peptide 8-22 compounds and methods of use thereof for treating pain
#1078Multimeric bicyclic peptide ligands
#1079BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1
#1080Methods and compositions useful for inhibiting growth of certain bacteria
#1081Compositions and methods for reducing ice crystal formation
#1082Peptide compositions and methods of use
#1083PEPTIDES DERIVED FROM TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 1 (TRPM1), COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
#1084Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair
#1085Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#1086Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#1087D-ENANTIOMERIC PEPTIDES FOR ANTI-INFLAMMATORY TREATMENT OF AMYOTROPIC LATERAL SCLEROSIS (ALS) AND OTHER DISEASES DRIVEN BY NEURO-INFLAMMATION
#1088TLR9 inhibitors to suppress inflammatory response to pathogens
#1089Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis
#1090Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic
#1091METAL-BINDING PEPTIDE AND USE THEREOF
#1092NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS
#1093Anti-inflammatory peptides and composition comprising the same
#1094Phage-peptide constructs for stimulating an immune response against CD47
#1095Bioactive peptides having detrimental effects on pest slugs
#1096Erythrocyte-binding therapeutics
#1097Bicyclic peptide ligands with detectable moieties and uses thereof
#1098Bis-thioether stapled peptides as inhibitors of PRC2 function
#1099Modulation of structured polypeptide specificity
#1100Peptide hydrogels and use thereof
#1101METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES
#1102Peptides Having Anti-Inflammatory Properties
#1103DIAGNOSTIC METHOD AND THERAPY
#1104Peptides that block transmission of orthotospoviruses and methods of using the same
#1105Surfactant adhesive composition
#1106CD40 targeted peptides and uses thereof
#1107Myotoxin-neutralizing peptides
#1108Modified peptides and associated methods of use
#1109Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides
#1110Heterotandem bicyclic peptide complex
#1111Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
#1112Diagnostic kit
#1113Peptide-compound cyclization method
#1114Immunogenic composition
#1115Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides
#1116Anti HLA-G specific antibodies
#1117PEPTIDES
#1118Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering
#1119PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#1120Functional polypeptide and its application thereof in preparing medicament for preventing and treating pulmonary fibrosis
#1121ANDRIAS DAVIDIANUS CARTILAGE PREPARATION
#1122Bicyclic peptide ligands and uses thereof
#1123Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases
#1124Heterotandem bicyclic peptide complex
#1125Cancer Antigen Peptide
#1126Compositions comprising cyclic peptides derived from an A-beta peptide
#1127Nucleic acid nanocapsules for drug delivery and targeted gene knockdown
#1128PEPTIDES
#1129Treatments for Gastrointestinal Disorders
#1130Compstatin Analogs With Improved Pharmacokinetic Properties
#1131Peptides and nanoparticles for intracellular delivery of molecules
#1132Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
#1133Peptides for cancer treatment
#1134Compositions and methods for transport across the blood brain barrier
#1135Methods for making and using antimicrobial peptides
#1136Targeting G3BP aggregation to prevent neurodegeneration
#1137FILL-FINISH PROCESS FOR PEPTIDE SOLUTIONS
#1138Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1139ANTI-FOULING PAINTS AND COATINGS
#1140Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
#1141PEPTIDES
#1142METHOD OF GENERATING INTERACTING PEPTIDES
#1143Manganese-based chelate conjugates for molecular MR imaging
#1144INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS
#1145Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
#1146Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1147Peptides with anti-cancer activity
#1148Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
#1149Engineered cascade components and cascade complexes
#1150Metal nanocluster scaffolds
#1151Structure-based peptide inhibitors of α-synuclein aggregation
#1152Bone fracture repair by targeting of agents that promote bone healing
#1153PD-1 Peptide Inhibitors
#1154Peptides and methods for the treatment of diabetes
#1155Compositions and methods for inhibiting lactate dehydrogenase a activity
#1156NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#1157PD-1 peptide inhibitors
#1158METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS
#1159Chimeric polypeptides and uses thereof
#1160PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE
#1161Peptide conjugates
#1162Ultra-pure agonists of guanylate cyclase C, method of making and using same
#1163IL-2alpha receptor subunit binding compounds
#1164Compositions and methods for inhibiting CD279 interactions
#1165Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
#1166Peptide based PCSK9 vaccine
#1167SELF-ASSEMBLING PEPTIDE COMPOSITIONS
#1168THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#1169Method for conjugating antibody and physiologically active substance
#1170Influenza peptides and compositions
#1171Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers
#1172FUSION PROTEIN
#1173Compounds and methods for treating tight junction permeabtility
#1174Compositions and methods of inhibiting the binding of plasma IgG autoantibodies to serotonin 2A receptor
#1175Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
#1176Immunogenic WT-1 peptides and methods of use thereof
#1177Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#1178NOVEL METHODS FOR DISPLAYING CYCLIC PEPTIDES ON BACTERIOPHAGE PARTICLES
#1179MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#1180MODIFIED BISPECIFIC T CELL RECEPTORS
#1181Antimicrobial peptides and methods of using same
#1182Signal molecules as cell penetration agents
#1183Pharmaceutically acceptable salts of polypeptides and methods of inhibiting the interaction between psd-95 and n-methyl-d-aspartic acid receptor (nmdar)
#1184USE OF EXCITATORY NERVE INJURY-RELATED POLYPEPTIDE IN PREVENTING, ALLEVIATING OR TREATING PAIN
#1185Chloride salt of TAT-NR2B9C
#1186FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#1187Methods of making anti-GP41 antibody-specific capture agents
#1188NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#1189FRAGMENTS OF P97 AND USES THEREOF
#1190Engineering AAV
#1191LAG3 binding peptides
#1192GRP78-derived peptide for identifying high-efficiency stem cells
#1193HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION
#1194COMPOSITION AND METHOD FOR TREATING A PATIENT HAVING LIVER CIRRHOSIS
#1195Peptides and other agents for treating pain and increasing pain sensitivity
#1196CYSTEINE PEPTIDE-ENABLED ANTIBODIES
#1197Methods and compositions for preventing influenza infection
#1198CONJUGATE OF WT1-DERIVED PEPTIDES AND COMPOSITION COMPRISING THE SAME
#1199Molecular Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Deposition in the Placenta
#1200Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases